JNK-IN-8
SIGMA/SML1246 - ≥96% (HPLC)
Synonym: 3-
CAS Number: 1410880-22-6
Empirical Formula (Hill Notation): C29H29N7O2
Molecular Weight: 507.59
MDL Number: MFCD22124890
Linear Formula: C29H29N7O2
Product Type: Chemical
| assay | ≥96% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C29H29N7O2/c1-20-17-24 |
| InChI key | GJFCSAPFHAXMSF-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(C1=CC(NC(C=CCN(C)C)=O |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | 2-8°C |
| Application: | JNK-IN-8 has been used as an inhibitor to address the importance of JNK signaling in withaferin A (WFA)-induced apoptosis of myelodysplastic syndromes (MDS)-L cells. |
| Biochem/physiol Actions: | JNK-IN-8 and lapatinib synergistically reduce cell viability in human triple negative breast cancers (TNBC) cell lines by inducing apoptosis. JNK-IN-8 and lapatinib result in accumulation of cytotoxic oxidative stress. |
| Biochem/physiol Actions: | JNK-IN-8 is a potent, selective and irreversible inhibitor of JNK1/2/3 that inhibits phosphorylation of c-Jun. JNK-IN-8 forms covalent bonds with a conserved cysteine residue. |
| Biochem/physiol Actions: | JNK-IN-8 is a potent, selective and irreversible inhibitor of JNK1/2/3. |
| Other Notes: | JNK-IN-8 has been expertly reviewed and recommended by the Chemical Probes Portal. For more information, please visit the JNK-IN-8 probe summary ![]() |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥96% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

